Dr. Pelech received his B.Sc. (1979, Honours) and Ph.D. (1982) degrees in Biochemistry from the University of British Columbia (UBC). He undertook five years of postdoctoral training with Sir Philip Cohen at the University of Dundee in Scotland and Nobel laureate Dr. Edwin Krebs at the Howard Hughes Medical Center at the University of Washington in Seattle. In 1987, he was one of the founding scientists of the Biomedical Research Centre at UBC, and he joined the UBC faculty as an assistant professor in the Department of Medicine in 1988.
He has been a full professor at UBC since 1997.
Concurrently, Dr. Pelech was the principal founder of Kinetek Pharmaceuticals, Inc. in 1992, and served as its president for 6 years.
In 1999, he founded Kinexus Bioinformatics Corporation, and has also been its president and chief scientific officer for over 19 years. Since 1988, Dr. Pelech has been an active member of the UBC Experimental Medicine Graduate Program Committee, a course instructor in graduate courses in this program (including MEDI-501, MED-502 and MEDI-590), and a direct research supervisor for over 12 graduate students and 150 undergraduate coop–education trainees.
You can read more about his background here: https://neurology.med.ubc.ca/faculty-listing/academic/dr-steven-pelech/
That all said, Dr. Pelech has serious concerns about the mRNA "vaccine," especially as applies to use on those under age of 50. He warns that young people ought not to take the vaccine because risks from the unknown do not appear to outweigh the relative benefits.
Watch his interview here:
You can watch another roundtable discussion with him and several other highly-credentialed doctors and researchers here:
https://trialsitenews.com/covid-19-expert-panel-the-path-forward-for-canadians-trialsite-webinar/
